L-156602
L-156602 is a C5a receptor antagonist. L-156602 inhibits inflammation, and the migration of monocytes and neutrophils to the infiltrating site in mouse inflammatory models. L-156602 suppresses the efferent phase of delayed-type hypersensitivity (DTH).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 125228-51-5
- Formel: C38H64N8O13
- Molecular Weight:840.96
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
L-156602 (0.2-0.5 mg/kg, i.p.) suppressed the infiltration of mononuclear leukocytes and neutrophils into the site of inflammation in PCI-induced inflammation of DBA/1 mice[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:
-
Dosage:0.1, 0.5 mg/kg, once daily for 3 days
-
Administration:Intraperitoneal injection (i.p.)
-
Result:Suppressed the swelling completely after 4 h at 0.1 mg/kg, and the effect was still statistical after 24 h at 0.5 mg/kg.
Reduced the number of migrated leukocytes.
Suppressed the migration of neutrophils, macrophages and lymphocytes non-specifically.
-
Animal Model:MDP-induced acute joint inflammation of BALB/c mice[1]
-
Dosage:0.25, 0.5 mg/kg, once daily for 3 days
-
Administration:Intraperitoneal injection (i.p.)
-
Result:Suppressed adjuvant arthritis although a slight reduction of body weight at the dose of 0.5 mg/kg after 24 h.
-
Animal Model:0.5% PCI-induced inflammation of DBA/1 mice[2]
-
Dosage:0.2, 0.5 mg/kg
-
Administration:Intraperitoneal injection (i.p.)
-
Result:Suppressed ear swelling significantly and the infiltration of mononuclear leukocytes and neutrophils into the site of inflammation.
-
Animal Model:5% PCI-induced inflammation of DBA/1 mice[2]
-
Dosage:0.4 mg/kg
-
Administration:Intraperitoneal injection (i.p.)
-
Result:Suppressed the infiltration of mononuclear leukocytes and neutrophils into the site of inflammation non-specifically.
Chemical Information
-
CAS. Nr. 125228-51-5
-
Molecular Weight 840.96
-
Formel C38H64N8O13
-
SMILES
CC[C@@H](C[C@H]1CC[C@@]([C@@](C(N[C@H]2[C@H](C(C)C)OC([C@@H](C)N(O)C([C@H]3CCCNN3C(CNC([C@H](C)N(O)C([C@@H]4CCCNN4C2=O)=O)=O)=O)=O)=O)=O)(O)C)(O)O[C@@H]1C)C
-
Synonyms
Antibiotic L 156602; PD 124966
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Tsuji RF, et al. Effects of L-156,602, a C5a receptor antagonist, on mouse experimental models of inflammation. Biosci Biotechnol Biochem. 1992 Dec;56(12):2034-6. [Content Brief]
[2]. Tsuji RF, et al. Anti-inflammatory effects and specificity of L-156,602: comparison of effects on concanavalin A and zymosan-induced footpad edema, and contact sensitivity response. Immunopharmacology. 1995 Feb;29(1):79-87. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
L-156602 Related Classifications
HY-16384 Related Classifications
Powered by Bioz